Viewing Study NCT05417750


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-02-25 @ 7:08 PM
Study NCT ID: NCT05417750
Status: COMPLETED
Last Update Posted: 2025-12-10
First Post: 2022-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of GC101 TIL in Advanced Solid Tumors
Sponsor: Shanghai Juncell Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tumor Infiltrating Lymphocytes View
None Safety View
None Advanced Solid Tumor View
None Immunotherapy View
None Efficacy View
None Adverse Drug Event View
Keywords: